“Smoker's paradox” in patients with cardiogenic shock complicating myocardial infarction - A substudy of the IABP-SHOCK II-trial and registry

International Journal of Cardiology

Volumn 222, Issue , 2016, Pages 775-779

  Saad, Mohammed ^a,b   Fuernau, Georg ^a,b   Desch, Steffen ^a,b   Eitel, Ingo ^a,b   Jung, Christian ^c   Pöss, Janine ^a,b   Schneider, Steffen ^d   Schuler, Gerhard ^e   Werdan, Karl ^f   Zeymer, Uwe ^d   Thiele, Holger ^a,b  

^a University Heart Center Lübeck   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d KLINIKUM LUDWIGSHAFEN   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Caridogenic shock; Myocardial infarction; Outcome; Smoker's paradox; Smoking

Indexed keywords

CREATININE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL TRIAL (TOPIC); COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; INTRAAORTIC BALLOON PUMP; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; SEX RATIO; SMOKING; ADVERSE EFFECTS; CLINICAL TRIAL; COMPLICATION; GERMANY; HEART ASSIST DEVICE; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REGISTER; SHOCK, CARDIOGENIC; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS;

AGED; FEMALE; GERMANY; HEART-ASSIST DEVICES; HUMANS; INCIDENCE; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REGISTRIES; SHOCK, CARDIOGENIC; SMOKING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84981333816     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.07.172     Document Type: Article

References (34)

1. [1] Babaev, A., Frederick, P.D., Pasta, D.J., Every, N., Sichrovsky, T., Hochman, J.S., Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294:4 (2005), 448–454.
2. [2] Goldberg, R.J., Spencer, F.A., Gore, J.M., Lessard, D., Yarzebski, J., Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 119:9 (2009), 1211–1219.
3. [3] Jeger, R.V., Radovanovic, D., Hunziker, P.R., Pfisterer, M.E., Stauffer, J.C., Erne, P., et al. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann. Intern. Med. 149:9 (2008), 618–626.
4. [4] Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364:9438 (2004), 937–952.
5. [5] Kawano, H., Soejima, H., Kojima, S., Kitagawa, A., Ogawa, H., Sex differences of risk factors for acute myocardial infarction in Japanese patients. Circ. J. 70:5 (2006), 513–517.
6. [6] Yagi, H., Komukai, K., Hashimoto, K., Kawai, M., Ogawa, T., Anzawa, R., et al. Difference in risk factors between acute coronary syndrome and stable angina pectoris in the Japanese: smoking as a crucial risk factor of acute coronary syndrome. J. Cardiol. 55:3 (2010), 345–353.
7. [7] Kelly, T.L., Gilpin, E., Ahnve, S., Henning, H., Ross, J. Jr., Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am. Heart J. 110:3 (1985), 535–541.
8. [8] Weisz, G., Cox, D.A., Garcia, E., Tcheng, J.E., Griffin, J.J., Guagliumi, G., et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction—the smoker's paradox revisited. Am. Heart J. 150:2 (2005), 358–364.
9. [9] Katayama, T., Iwasaki, Y., Sakoda, N., Yoshioka, M., The etiology of ‘smoker's paradox’ in acute myocardial infarction with special emphasis on the association with inflammation. Int. Heart J. 49:1 (2008), 13–24.
10. [10] Aune, E., Roislien, J., Mathisen, M., Thelle, D.S., Otterstad, J.E., The “smoker's paradox” in patients with acute coronary syndrome: a systematic review. BMC Med., 9, 2011, 97.
11. [11] Himbert, D., Golmard, J.L., Juliard, J.M., Feldman, L.J., Steg, P.G., Impact of smoking on the incidence and survival of cardiogenic shock complicating acute myocardial infarction treated with reperfusion therapy. Am. J. Cardiol. 89:1 (2002), 73–75.
12. [12] Windecker, S., Kolh, P., Alfonso, F., Collet, J.P., Cremer, J., Falk, V., et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 35:37 (2014), 2541–2619.
13. [13] Thiele, H., Schuler, G., Neumann, F.J., Hausleiter, J., Olbrich, H.G., Schwarz, B., et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am. Heart J. 163:6 (2012), 938–945.
14. [14] Thiele, H., Zeymer, U., Neumann, F.J., Ferenc, M., Olbrich, H.G., Hausleiter, J., et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N. Engl. J. Med. 367:14 (2012), 1287–1296.
15. [15] Thiele, H., Zeymer, U., Neumann, F.J., Ferenc, M., Olbrich, H.G., Hausleiter, J., et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382:9905 (2013), 1638–1645.
16. [16] Werdan, K., Russ, M., Buerke, M., Delle-Karth, G., Geppert, A., Schondube, F.A., Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline. Dtsch. Arztebl. Int. 109:19 (2012), 343–351.
17. [17] Andrikopoulos, G.K., Richter, D.J., Dilaveris, P.E., Pipilis, A., Zaharoulis, A., Gialafos, J.E., et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the “smoker's paradox” in a countrywide study. Eur. Heart J. 22:9 (2001), 776–784.
18. [18] Gourlay, S.G., Rundle, A.C., Barron, H.V., Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2). Nicotine Tob. Res. 4:1 (2002), 101–107.
19. [19] Barbash, G.I., White, H.D., Modan, M., Diaz, R., Hampton, J.R., Heikkila, J., et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 87:1 (1993), 53–58.
20. [20] Barbash, G.I., Reiner, J., White, H.D., Wilcox, R.G., Armstrong, P.W., Sadowski, Z., et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the “smoker's paradox” from the GUSTO-I trial, with angiographic insights. Global utilization of streptokinase and tissue-plasminogen activator for occluded coronary arteries. J. Am. Coll. Cardiol. 26:5 (1995), 1222–1229.
21. [21] Grines, C.L., Topol, E.J., O'Neill, W.W., George, B.S., Kereiakes, D., Phillips, H.R., et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 91:2 (1995), 298–303.
22. [22] Zahger, D., Cercek, B., Cannon, C.P., Jordan, M., Davis, V., Braunwald, E., et al. How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial). Am. J. Cardiol. 75:4 (1995), 232–236.
23. [23] Gottlieb, S., Boyko, V., Zahger, D., Balkin, J., Hod, H., Pelled, B., et al. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). J. Am. Coll. Cardiol. 28:6 (1996), 1506–1513.
24. [24] de Chillou, C., Riff, P., Sadoul, N., Ethevenot, G., Feldmann, L., Isaaz, K., et al. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis. J. Am. Coll. Cardiol. 27:7 (1996), 1662–1668.
25. [25] Kirtane, A.J., Martinezclark, P., Rahman, A.M., Ray, K.K., Karmpaliotis, D., Murphy, S.A., et al. Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 45:2 (2005), 321–323.
26. [26] Mahaffey, K.W., Yang, Q., Pieper, K.S., Antman, E.M., White, H.D., Goodman, S.G., et al. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. J. Gen. Intern. Med. 23:3 (2008), 310–316.
27. [27] Robertson, J.O., Ebrahimi, R., Lansky, A.J., Mehran, R., Stone, G.W., Lincoff, A.M., Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy). JACC Cardiovasc. Interv. 7:4 (2014), 372–379.
28. [28] Jaatun, H.J., Sutradhar, S.C., Dickstein, K., Comparison of mortality rates after acute myocardial infarction in smokers versus nonsmokers. Am. J. Cardiol. 94:5 (2004), 632–636 a9.
29. [29] Symons, R., Masci, P.G., Francone, M., Claus, P., Barison, A., Carbone, I., et al. Impact of active smoking on myocardial infarction severity in reperfused ST-segment elevation myocardial infarction patients: the smoker's paradox revisited. Eur. Heart J., 2016.
30. [30] Fuernau, G., Eitel, I., Thiele, H., Smoke over myocardial infarction: cigarettes and reperfusion injury. Eur. Heart J., May 2 2016 pii: ehw111.
31. [31] Reinstadler, S.J., Eitel, C., Fuernau, G., de Waha, S., Desch, S., Mende, M., et al. Association of smoking with myocardial injury and clinical outcome in patients undergoing mechanical reperfusion for ST-elevation myocardial infarction. Eur. Heart J. Cardiovasc. Imaging, 2016.
32. [32] Gurbel, P.A., Bliden, K.P., Logan, D.K., Kereiakes, D.J., Lasseter, K.C., White, A., et al. The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. J. Am. Coll. Cardiol. 62:6 (2013), 505–512.
33. [33] Ali, S.F., Smith, E.E., Bhatt, D.L., Fonarow, G.C., Schwamm, L.H., Paradoxical association of smoking with in-hospital mortality among patients admitted with acute ischemic stroke. J. Am. Heart Assoc., 2(3), 2013, e000171.
34. [34] Pollock, J.S., Hollenbeck, R.D., Wang, L., Janz, D.R., Rice, T.W., McPherson, J.A., A history of smoking is associated with improved survival in patients treated with mild therapeutic hypothermia following cardiac arrest. Resuscitation 85:1 (2014), 99–103.